PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 27, 2026Medicina0 citationsOpen Access

High-Frequency TEOAE Amplitude Ratio Alterations in Newborns Exposed in Utero to Maternal SARS-CoV-2 Infection: A Prospective Cohort Study

View Full Paper
RMRita MalesciReproductive Science CenterGFGiovanni FredaFederico II University HospitalNSNicola SerraFederico II University Hospital

Key Points

  • This study aims to determine if in utero exposure to maternal COVID-19 affects cochlear function in newborns, as measured by TEOAE amplitude ratios.
  • Prospective cohort study conducted from October 2021 to September 2022.
  • Included 61 newborns from 30 mothers with SARS-CoV-2 infection and 31 controls without infection.
  • Audiological evaluations included TEOAE, ABR, and tympanometry to assess cochlear function.
  • No significant differences in ABR thresholds or TEOAE outcomes between groups were found.
  • Newborns exposed to SARS-CoV-2 showed significantly reduced TEOAE amplitude ratios at 2000 Hz (p=0.0077) and 4000 Hz (p=0.020).
  • The 4000 Hz amplitude ratio was identified as an independent negative predictor of in utero exposure (OR=0.75; p=0.0352).

Abstract

Background and Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy has raised concerns regarding possible fetal consequences, including potential effects on auditory system development. Although the current literature suggests that overt congenital hearing loss is uncommon among newborns exposed in utero, subtle cochlear functional alterations may not be detectable through conventional threshold-based screening alone. The objective of this study is to investigate whether in utero exposure to maternal COVID-19 is associated with early cochlear functional changes in newborns, as assessed by frequency-specific transient evoked otoacoustic emission (TEOAE) amplitude ratios, and to determine whether such alterations are accompanied by differences in click-evoked auditory brainstem response (ABR) thresholds. Materials and Methods: This prospective cohort study was conducted between October 2021 and September 2022 and included 61 pregnant women: 30 with laboratory-confirmed SARS-CoV-2 infection during pregnancy (study group) and 31 without documented infection (control group). All newborns underwent standardized audiological evaluation shortly after birth, including otoscopy, TEOAE, click-evoked ABR, and tympanometry. Frequency-specific TEOAE amplitude ratios at 500, 1000, 1500, 2000, and 4000 Hz were compared between groups. A logistic regression analysis was performed to identify audiological predictors of newborn exposure to SARS-CoV-2 in utero. Results: No significant differences were observed in ABR thresholds or in TEOAE “pass/refer” outcomes between the control and study groups, indicating the absence of clinically overt HL. However, newborns exposed to SARS-CoV-2 in utero showed significantly reduced TEOAE amplitude ratios at 2000 Hz (p = 0.0077) and 4000 Hz (p = 0.020). Logistic regression identified the 4000 Hz amplitude ratio as an independent negative predictor of in utero exposure (OR = 0.75; p = 0.0352). No significant differences were detected at lower frequencies. Conclusions: Maternal COVID-19 during pregnancy was not associated with immediate neonatal HL but was linked to subtle high-frequency cochlear functional modulation. Longitudinal audiological follow-up is needed to clarify the clinical significance of these findings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Malesci et al. (2026) studied this question.

synapsesocial.com/papers/6a168b160c924ddd1bd59e47https://doi.org/10.3390/medicina62050924
Ask AI
Helpful
Bookmark
Share
View Full Paper